NASDAQ:GHRS

Gh Research Stock Insider Trading

etoro logo Buy GHRS
*Your capital is at risk
$23.61
+1.52 (+6.88%)
At Close: Jun 23, 2026

GH Research Stock Insider Power

Based on the 17 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 687.7K and sold 0 GHRS shares in the last 17 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 17 transactions)
100.00
Buy 687.7K shares
Sell 0 shares
100% Buy Activity
Moderate Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 01, 2026
Buy
Ordinary Shares
Schonharting Florian
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Ordinary Shares
Moore Duncan
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Share Options (Right to Buy)
Moore Duncan
Director
Director 4 667
Value: $117
Mar 18, 2026
Buy
Share Options (Right to Buy)
Cameron Aaron Luke
Chief Operating Officer
C-Suite Officer 33 211
Value: $708.1K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Cameron Aaron Luke
Chief Operating Officer
C-Suite Officer 100 000
Value: $3K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Cameron Aaron Luke
Chief Operating Officer
C-Suite Officer 25 000
Value: $145.0K
Mar 18, 2026
Buy
Ordinary Shares
Hanley Dermot John
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Share Options (Right to Buy)
Hanley Dermot John
Director
Director 4 667
Value: $117
Mar 18, 2026
Buy
Ordinary Shares
Halle Magnus Clemensen
Managing Director, Ireland
Officer 0
Value: $0
Mar 18, 2026
Buy
Share Options (Right to Buy)
Halle Magnus Clemensen
Managing Director, Ireland
Officer 50 000
Value: $1K
Mar 18, 2026
Buy
Ordinary Shares
Forer Michael
Director
Director 0
Value: $0
Mar 18, 2026
Buy
Share Options (Right to Buy)
Forer Michael
Director
Director 4 667
Value: $117
Mar 18, 2026
Buy
Share Options (Right to Buy)
Valcheva Velichka
Chief Executive Officer
CEO / President 50 000
Value: $541.5K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Valcheva Velichka
Chief Executive Officer
CEO / President 35 000
Value: $265.7K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Valcheva Velichka
Chief Executive Officer
CEO / President 300 000
Value: $8K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Ryan Julie
Vp, Finance
Officer 50 487
Value: $622.0K
Mar 18, 2026
Buy
Share Options (Right to Buy)
Ryan Julie
Vp, Finance
Officer 30 000
Value: $750

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT GH RESEARCH PLC
GH Research
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE